Correlation Between Merck and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Revolution Medicines, you can compare the effects of market volatilities on Merck and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Revolution Medicines.

Diversification Opportunities for Merck and Revolution Medicines

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Merck and Revolution is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Merck i.e., Merck and Revolution Medicines go up and down completely randomly.

Pair Corralation between Merck and Revolution Medicines

Considering the 90-day investment horizon Merck is expected to generate 165.27 times less return on investment than Revolution Medicines. But when comparing it to its historical volatility, Merck Company is 3.01 times less risky than Revolution Medicines. It trades about 0.0 of its potential returns per unit of risk. Revolution Medicines is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2,415  in Revolution Medicines on August 28, 2024 and sell it today you would earn a total of  3,335  from holding Revolution Medicines or generate 138.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Revolution Medicines

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Revolution Medicines 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Merck and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Revolution Medicines

The main advantage of trading using opposite Merck and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Merck Company and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges